OTC Markets OTCPK - Delayed Quote USD

Nanosonics Limited (NNCSF)

Compare
2.7800
0.0000
(0.00%)
At close: April 2 at 4:00:00 PM EDT
Loading Chart for NNCSF
  • Previous Close 2.4000
  • Open 2.4000
  • Bid 2.7700 x 40000
  • Ask 3.1500 x 40000
  • Day's Range 2.4000 - 2.4000
  • 52 Week Range 1.6900 - 2.7800
  • Volume 20
  • Avg. Volume 66
  • Market Cap (intraday) 906.933M
  • Beta (5Y Monthly) 1.83
  • PE Ratio (TTM) 92.67
  • EPS (TTM) 0.0300
  • Earnings Date Feb 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

www.nanosonics.com.au

466

Full Time Employees

June 30

Fiscal Year Ends

Recent News: NNCSF

View More

Performance Overview: NNCSF

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

NNCSF
32.38%
S&P/ASX 200 [XJO] (^AXJO)
3.67%

1-Year Return

NNCSF
48.66%
S&P/ASX 200 [XJO] (^AXJO)
0.54%

3-Year Return

NNCSF
2.80%
S&P/ASX 200 [XJO] (^AXJO)
4.88%

5-Year Return

NNCSF
22.56%
S&P/ASX 200 [XJO] (^AXJO)
55.10%

Compare To: NNCSF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NNCSF

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    906.93M

  • Enterprise Value

    821.84M

  • Trailing P/E

    83.43

  • Forward P/E

    63.69

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.46

  • Price/Book (mrq)

    7.16

  • Enterprise Value/Revenue

    7.04

  • Enterprise Value/EBITDA

    46.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.00%

  • Return on Assets (ttm)

    3.24%

  • Return on Equity (ttm)

    9.09%

  • Revenue (ttm)

    183.97M

  • Net Income Avi to Common (ttm)

    16.56M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    144.48M

  • Total Debt/Equity (mrq)

    4.85%

  • Levered Free Cash Flow (ttm)

    24.7M

Research Analysis: NNCSF

View More

Company Insights: NNCSF

Research Reports: NNCSF

View More

People Also Watch